J.Pharma Research Guide · Anti-Aging & Melanocortin Peptides

What is MT-2 (Melanotan 2)?

MT-2, or Melanotan 2, is a synthetic cyclic heptapeptide modeled on alpha-melanocyte-stimulating hormone (α-MSH) — an endogenous hormone derived from the POMC (proopiomelanocortin) precursor protein. As a non-selective melanocortin receptor agonist, MT-2 activates the same receptor family that governs skin pigmentation, appetite signaling, and aspects of energy balance in preclinical research. It is one of the most studied synthetic alpha-MSH analogs, and its receptor pharmacology directly spawned the development of PT-141 (bremelanotide).

Research Use Only. All information on this page is for educational and research reference purposes. J.Pharma products are intended strictly for in vitro laboratory research. Not for human or veterinary use. Not FDA approved for any therapeutic purpose.

What MT-2 Is

Melanotan 2 is a cyclic heptapeptide — seven amino acids arranged in a ring structure — derived from the active core sequence of alpha-MSH. The cyclization confers greater conformational rigidity and enzymatic resistance compared to the linear parent peptide, resulting in a longer half-life in research preparations.

Alpha-MSH itself is a 13-amino-acid peptide cleaved from the POMC precursor in pituitary and hypothalamic neurons. It is the endogenous agonist at the melanocortin receptor family (MC1R through MC5R) and regulates pigmentation, energy intake, and several autonomic functions via these receptors.

🔬 Key Identification
Class: Synthetic cyclic α-MSH analog · 7 amino acids (cyclic) · Mechanism: Non-selective MC1R / MC3R / MC4R agonist · Research category: Anti-Aging / Pigmentation / CNS Melanocortin · Available size: 10mg

Mechanism of Action

MT-2 binds to melanocortin receptors — GPCRs primarily coupled to Gs proteins — activating adenylyl cyclase, raising intracellular cAMP, and triggering downstream PKA-mediated signaling cascades. The specific downstream outcome depends on which receptor subtype is activated and in which tissue.

MC1R — Melanogenesis: MC1R is expressed on epidermal melanocytes. Activation of MC1R by MT-2 increases cAMP, activates MITF (microphthalmia-associated transcription factor), and upregulates tyrosinase — the rate-limiting enzyme in melanin biosynthesis. The net result is a shift in pigment production toward eumelanin (brown/black) and away from pheomelanin (yellow/red). This is the pharmacological basis for MT-2's sunless tanning research applications.

MC3R — Hypothalamic Energy Balance: MC3R is expressed in the hypothalamus and other brain regions involved in energy homeostasis. Research suggests MC3R plays a modulatory role in the melanocortin system's energy-sensing function, including feedback regulation of the central melanocortin tone.

MC4R — Appetite and CNS Effects: MC4R, broadly expressed throughout the central nervous system, is one of the most studied melanocortin receptors in the context of energy intake, appetite suppression, and sexual arousal. MC4R is the primary target of the downstream research line that produced PT-141 (bremelanotide).

"MT-2 acts at all three CNS-relevant melanocortin receptors — MC1R for pigmentation, MC3R for energy balance modulation, and MC4R for appetite and arousal pathways — making it a non-selective but broadly informative research tool."
J.Pharma Research Notes

Melanocortin Receptor Map

ReceptorPrimary LocationMT-2 ActivityResearch Relevance
MC1RSkin melanocytesAgonistMelanogenesis; eumelanin vs pheomelanin ratio; photoprotection
MC2RAdrenal cortexNot activated (ACTH-selective)Cortisol / adrenal axis — not a target of MT-2
MC3RHypothalamus, limbicAgonistEnergy balance feedback; central melanocortin tone regulation
MC4RCNS (broad)AgonistAppetite suppression; libido research; metabolic rate
MC5RExocrine glands, muscleLow affinitySebaceous gland secretion; minor relevance to most MT-2 research

Research Applications

MT-2 has been studied across several distinct research domains, reflecting the distribution of its receptor targets:

Research AreaReceptor PathwayNotes
Melanogenesis & pigmentationMC1R → MITF → tyrosinaseEumelanin upregulation; the original research purpose of the compound
Photoprotection mechanismsMC1R → eumelaninHigher eumelanin density studied for UV-absorption capacity in skin models
Appetite regulationMC4R (hypothalamic)Studies on food intake suppression and energy balance in CNS models
Body composition researchMC3R / MC4ROften studied alongside appetite and energy expenditure endpoints
Melanocortin receptor pharmacologyMC1R / MC3R / MC4RUsed as a non-selective reference agonist in receptor binding and selectivity studies

MT-2 vs PT-141 (Bremelanotide)

PT-141 (bremelanotide) emerged directly from the MT-2 research line. Understanding the two compounds requires understanding what was changed and why:

Shared origin: Both MT-2 and PT-141 are cyclic heptapeptide analogs of alpha-MSH and act on the melanocortin receptor family. PT-141 is a metabolite of MT-2 — specifically, it lacks MT-2's C-terminal amide and exhibits slightly altered receptor pharmacology as a result.

Receptor selectivity: MT-2 is non-selective across MC1R, MC3R, and MC4R. PT-141 retains strong MC3R and MC4R activity but shows significantly reduced MC1R affinity — meaning its research profile de-emphasizes melanogenesis and places greater focus on the CNS-mediated effects (particularly libido and appetite research) associated with MC3R/MC4R activation.

In research practice: Researchers studying CNS melanocortin pathways in isolation — without the confounding variable of peripheral MC1R/pigmentation activity — typically prefer PT-141. Researchers studying the full melanocortin receptor spectrum, or specifically investigating MC1R pharmacology and melanogenesis, continue to use MT-2.

📦 Both available from J.Pharma
MT-2 Melanotan 2 — 10mg — $30 · View product →
PT-141 Bremelanotide — 10mg — $50 · View product →

Reconstitution for Research

MT-2 is supplied as a lyophilized (freeze-dried) powder and must be reconstituted with Bacteriostatic Water before use in research protocols. MT-2 requires light protection throughout handling.

Standard protocol for the 10mg vial: Add 1–2 mL Bacteriostatic Water for a concentration of 5–10 mg/mL. Inject BAC Water slowly down the vial wall — do not aim directly at the lyophilized cake. Swirl gently until dissolved; do not shake, as this can introduce bubbles and potentially degrade the peptide. The resulting solution should be clear and colorless.

Light protection is critical: MT-2 undergoes photodegradation when exposed to UV and prolonged visible light. Immediately after reconstitution, wrap the vial in foil or place it in a dark container. Store at 2–8°C. Stable 28–42 days after reconstitution when kept refrigerated and light-protected.

For complete reconstitution parameters and a dosing calculator that computes exact draw volumes for your target concentration, visit our Reconstitution Guide and Dosing Calculator. For general peptide storage best practices, see our Peptide Storage 101 guide.

Frequently Asked Questions

What is Melanotan 2 (MT-2)?
Melanotan 2 (MT-2) is a synthetic cyclic heptapeptide and analog of alpha-melanocyte-stimulating hormone (alpha-MSH). Originally developed in sunless tanning research, it acts as a non-selective melanocortin receptor agonist with activity at MC1R, MC3R, and MC4R — receptors found in skin and the central nervous system respectively.
How does MT-2 differ from PT-141?
Both MT-2 and PT-141 (bremelanotide) are melanocortin receptor agonists derived from the same alpha-MSH research line. MT-2 is non-selective — it activates MC1R, MC3R, and MC4R. PT-141 was developed with greater selectivity toward MC3R and MC4R (the CNS-expressed receptors) and reduced MC1R activity, making its research profile more focused on appetite and libido pathways than on melanogenesis.
What does MC1R activation do in research?
MC1R is expressed on melanocytes in skin. When activated by alpha-MSH or analogs like MT-2, it stimulates melanogenesis via a Gs-protein-coupled pathway that increases intracellular cAMP and activates MITF, upregulating tyrosinase expression and shifting pigment production toward eumelanin.
Why is MT-2 light-sensitive?
Cyclic peptides like MT-2 can undergo photodegradation when exposed to UV or prolonged visible light. Both the lyophilized powder and the reconstituted solution should be protected from light — keep in original foil packaging and store the reconstituted vial wrapped in foil or in a dark container at 2–8°C.
How do I reconstitute MT-2?
Reconstitute the 10mg vial with 1–2 mL Bacteriostatic Water for a concentration of 5–10 mg/mL. Inject BAC Water slowly down the vial wall and swirl gently — do not shake. Immediately protect from light. Store at 2–8°C, foil-wrapped, for up to 28–42 days after reconstitution.
Regulatory Notice

None of the statements on this website have been reviewed or approved by the U.S. Food and Drug Administration. J.Pharma products are not intended to diagnose, treat, cure, or prevent any disease or medical condition. All products are sold strictly for in vitro laboratory research purposes. They are not for human or animal use of any kind. DiPerna Services, LLC d/b/a J.Pharma is not a compounding pharmacy or outsourcing facility as defined under Sections 503A and 503B of the Federal Food, Drug, and Cosmetic Act.